Pneumococcal Vaccine Extended to High-Risk Children, Teens

by | Jun 19, 2026 | Health

Spread the love
FDA approves expanded indication for individuals aged 2-17 years with chronic medical conditions.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments